Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Osiris Therapeutics Inc (NASDAQ:OSIR)

5.64
Delayed Data
As of 12:48pm ET
 +0.05 / +0.89%
Today’s Change
3.55
Today|||52-Week Range
23.39
-45.66%
Year-to-Date
MiMedx Goes After Osiris With Lawsuit
May 19 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close5.59
Today’s open5.58
Day’s range5.48 - 5.70
Volume41,077
Average volume (3 months)213,419
Market cap$187.8M
Dividend yield--
Data as of 12:48pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)+78.54%
Earnings growth (this year)+260.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+146.29%
P/E ratio115.2
Price/Sales9.15
Price/Book2.23

Competitors

 Today’s
change
Today’s
% change
CYTRCytRx Corp0.000.00%
AXSMAxsome Therapeutics ...-0.15-1.67%
ENZYEnzymotec Ltd-0.03-0.37%
EVGNEvogene Ltd-0.18-2.55%
Data as of 12:49pm ET, 05/26/2016

Financials

Last reporting dateMay 26, 2016
EPS forecast (this quarter)$0.01
Annual revenue (last year)$59.9M
Annual profit (last year)-$1.8M
Net profit margin-0.41%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Bobby Dwayne Montgomery
Chief Operating Officer
Frank D. Czworka
Corporate headquarters
Columbia, Maryland

Forecasts

Partner Offers

Search for Jobs